Zevra Therapeutics Inc. (ZVRA) — Cash Flow Reinvestment Rate
Zevra Therapeutics Inc. (ZVRA) has a Cash Flow Reinvestment Rate of 1.09x as of September 2025, reinvesting $5.13 Million (capex $554.00K plus investments $-4.58 Million) from operating cash flow of $4.71 Million. Explore Zevra Therapeutics Inc. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zevra Therapeutics Inc. Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Zevra Therapeutics Inc. across 1 annual periods. Also explore ZVRA asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zevra Therapeutics Inc. (2021–2021)
Year-by-year capital reinvestment analysis for Zevra Therapeutics Inc.. For live market cap and broader valuation context, see ZVRA market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.50x | $15.63 Million | $10.44 Million | $102.00K | — |